Tower Research Capital LLC (Trc) Aridis Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.16 - $0.4 $2,364 - $5,911	14,779 Added 933.02%	16,363 $3,000
Q1 2023 May 09, 2023	SELL	$0.31 - $1.5 $2,494 - $12,069	-8,046 Reduced 83.55%	1,584 $0
Q4 2022 Feb 10, 2023	SELL	$0.81 - $1.18 $841 - $1,226	-1,039 Reduced 9.74%	9,630 $11,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $2.47 $1,892 - $6,402	2,592 Added 32.09%	10,669 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $1.7 $4,386 - $8,194	4,820 Added 147.99%	8,077 $9,000
Q1 2022 May 12, 2022	BUY	$1.33 - $2.59 $4,048 - $7,883	3,044 Added 1429.11%	3,257 $6,000
Q4 2021 Feb 14, 2022	SELL	$2.0 - $3.65 $2,972 - $5,423	-1,486 Reduced 87.46%	213 $0
Q3 2021 Nov 15, 2021	BUY	$3.55 - $7.49 $2,296 - $4,846	647 Added 61.5%	1,699 $6,000
Q2 2021 Aug 16, 2021	BUY	$5.3 - $7.4 $5,575 - $7,784	1,052 New	1,052 $8,000
Q1 2021 May 17, 2021	SELL	$5.54 - $8.1 $3,617 - $5,289	-653 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.07 - $8.01 $3,963 - $5,230	653 New	653 $4,000
Q3 2019 Nov 05, 2019	SELL	$6.57 - $12.2 $249 - $463	-38 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$7.1 - $11.34 $269 - $430	38 New	38 $0
Q1 2019 May 14, 2019	SELL	$8.15 - $11.59 $1,287 - $1,831	-158 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.82 - $13.03 $3,651 - $6,085	-467 Reduced 74.72%	158 $2,000
Q3 2018 Nov 13, 2018	BUY	$11.92 - $13.69 $7,450 - $8,556	625 New	625 $8,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.